Environmental and Biological Monitoring

  • John D. Osterloh
  • Alyce Bezman Tarcher


Human populations are increasingly exposed to large numbers of chemicals that pose potential health risks. To understand and prevent the hazards of exposure to a chemical, precise information is required concerning its concentration in the environment and its concentration within the body in relation to its adverse health effects. It is widely acknowledged that assessment of the health risks of pollutant exposure is greatly impeded by imprecise exposure data (97, 191, 204, 206).


Methyl Mercury Organochlorine Pesticide Lead Exposure Blood Lead Level Sister Chromatid Exchange 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agency for Toxic Substances and Disease Registry: The Nature and Extent of Lead Poisoning in Children in the United States: A Report to Congress, US Department of Health and Human Services, Public Health Services, Washington, 1988.Google Scholar
  2. 2.
    Aitio A, Riihimäki V, Vainio H (eds.): Biological Monitoring and Surveillance of Workers Exposed to Chemicals, Hemisphere Publishing, Washington, 1984.Google Scholar
  3. 3.
    Aitio A, Järvisalo J, Riihimäki V, et al: Biological monitoring. In: Occupational Medicine: Principles and Practical Applications, 2nd ed, p 178, Zenz C (ed.), Year Book Medical Publishers, Chicago, 1988.Google Scholar
  4. 4.
    Aldridge WN, Barnes JM, Johnson MK: Studies on delayed neurotoxicity produced by some organo-phosphate compounds. Ann NY Acad Sci 160:314, 1969.PubMedCrossRefGoogle Scholar
  5. 5.
    Alessio L, Castoldi MR, Monelli O, et al: Indicators of internal dose in current and past exposure to lead. Int Arch Occup Environ Health 44:127, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    American Conference of Governmental Industrial Hygienists: Threshold Limit Values and Biological Exposure Indices for 1987–1988, American Conference of Governmental Industrial Hygienists, Cincinnati, Ohio, 1987.Google Scholar
  7. 7.
    Ames BN: Dietary carcinogens and anticarcinogens. Science 221:1256, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson EW, Andelman JM, Strauch NJ, et al: Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris: A study on 10 patients with ischemic heart disease. Ann Intern Med 79:46, 1973.PubMedCrossRefGoogle Scholar
  9. 9.
    Awa AA, Sofuni T, Honda T, et al: Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki. J Radiat Res (Toyko) 19:126, 1978.CrossRefGoogle Scholar
  10. 10.
    Baker EL Jr, Peterson WA, Holtz JL, et al: Subacute cadmium intoxication in jewelry workers: An evaluation of diagnostic procedures. Arch Environ Health 34:73, 1979.CrossRefGoogle Scholar
  11. 11.
    Bakir F, Damluji SF, Amin-Zaki L, et al: Methylmer-cury poisoning in Iraq. Science 181:230, 1973.PubMedCrossRefGoogle Scholar
  12. 12.
    Bartsch H, Hemminki K, O’Neill IK (eds.): Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, LARC Scientific Publication 89, International Agency for Research on Cancer, Lyon, 1988.Google Scholar
  13. 13.
    Baselt RC, Cravey RH: Disposition of Toxic Drugs and Chemicals in Man, 3rd ed., Year Book Medical Publishers, Chicago, 1989.Google Scholar
  14. 14.
    Bastable MD: β2-Microglobulin in urine: Not suitable for assessing renal tubular function. Clin Chem 29:996, 1983.PubMedGoogle Scholar
  15. 15.
    Bell ZG, Lovejoy HB, Vizena TR: Mercury exposure evaluations and their correlations with mercury excretions. J Occup Med 15:501, 1973.PubMedGoogle Scholar
  16. 16.
    Bellinger D, Leviton A, Needleman HL, et al: Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol 8:151, 1986.PubMedGoogle Scholar
  17. 17.
    Bellinger D, Leviton A, Waternaux C, et al: Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316:1037, 1987.PubMedCrossRefGoogle Scholar
  18. 18.
    Berlin A, Wolff AH, Hasegawa Y (eds.): The Use of Biological Specimens for the Assessment of Human Exposure to Environmental Pollutants, Martinus Nijhoff, The Hague, 1979.Google Scholar
  19. 19.
    Berlin A, Draper M, Kemminki K, et al. (eds.): Monitoring Human Exposure to Carcinogenic and Mutagenic Agents. International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  20. 20.
    Berlin M, Gage JC, Gullberg B, et al: Breath concentration as an index of the health risk from benzene. Scand J Work Environ Health 6:104, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    Berman E: Toxic Metals and their Analysis, Heyden and Son, London, 1980.Google Scholar
  22. 22.
    Bernard AM, Lauwerys RR: Retinol binding protein in urine: A more practical index than urinary β2-microglobulin for the routine screening of renal tubular function. Clin Chem 27:1781, 1981.PubMedGoogle Scholar
  23. 23.
    Bernard AM, Lauwerys MD: Present status and trends in biological monitoring of exposure to industrial chemicals. J Occup Med 28:558, 1986.PubMedCrossRefGoogle Scholar
  24. 24.
    Blair A, Stewart P, O’Berg M, et al: Mortality among industrial workers exposed to formaldehyde. J Natl Cancer Inst 76:1071, 1986.PubMedGoogle Scholar
  25. 25.
    Blair A, Stewart P, Hoover RN, et al: Letter to the editor: Cancer of the nasopharnyx and oropharynx and exposure to formaldehyde. J Natl Cancer Inst 78:191, 1987.PubMedGoogle Scholar
  26. 26.
    Bloom DA (ed.): Guidelines for Studies of Human Populations Exposed to Mutagenic and Reproductive Hazards, March of Dimes Birth Defects Foundation, New York, 1981.Google Scholar
  27. 27.
    Bordo B, Mossetto N, Musicco M, et al: Electrophysiologic changes in workers with “low” blood lead levels. Am J Ind Med 3:23, 1982.PubMedCrossRefGoogle Scholar
  28. 28.
    Bowers MB, Goodman E, Sim VM: Some behavioral changes in man following anticholinesterase administration. J Nerv Ment Dis 138:383–389, 1964.PubMedCrossRefGoogle Scholar
  29. 29.
    Brandom WF, Saccomanno G, Archer PG, et al: Chromosome aberrations as a biological dose response indicator of radiation exposure in uranium miners. Radiat Res 76:159, 1978.PubMedCrossRefGoogle Scholar
  30. 30.
    Brookes P, Lawley PD: Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: Relation between carcinogenic power of hydrocarbons and their binding of deoxyribonucleic acid. Nature 202:781, 1964.PubMedCrossRefGoogle Scholar
  31. 31.
    Brown JF Jr, Lawton RV: Polychlorinated biphenyl (PCB) partitioning between adipose tissue and serum. Bull Environ Contam Toxicol 33:277, 1984.PubMedCrossRefGoogle Scholar
  32. 32.
    Buchet JP, Lauwerys R, Roels H: Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate, or dimethylarsinite in man. Int Arch Occup Environ Health 48:71, 1981.PubMedCrossRefGoogle Scholar
  33. 33.
    Buchet JP, Lauwerys R, Roels H: Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 48:111, 1981.PubMedCrossRefGoogle Scholar
  34. 34.
    Burse VW, Kimbrough RD, Vlllanueva EC, et al: Polychlorinated biphenyls. Storage, distribution, excretion, and recovery: Liver morphology after prolonged dietary ingestion. Arch Environ Health 29: 301, 1974.PubMedCrossRefGoogle Scholar
  35. 35.
    Byard JL: The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in human adipose tissue. J Toxicol Environ Health 22:381, 1987.PubMedCrossRefGoogle Scholar
  36. 36.
    Cairns T, Siegmund EG: PCBs: Regulatory history and analytical problems. Anal Chem 53:1183A, 1981.Google Scholar
  37. 37.
    Calleman CJ: Monitoring of background levels of hydroxyethyl adducts in human hemoglobin. In: Genetic Toxicology of Environmental Chemicals, Part B: Genetic Effects and Applied Mutagenesis, p 261, Ramel C, Lambert B, Magnusson J (eds.), Alan R Liss, New York, 1986.Google Scholar
  38. 38.
    Calleman CJ, Ehrenberg L, Jansson B, et al: Monitoring and risk assessment by means of alkygroups in hemoglobin in persons occupationally exposed to ethylene oxide. J Environ Pathol Toxicol 2:427, 1978.PubMedGoogle Scholar
  39. 39.
    Carton MJ, Harrison MJ, Fullerton PM, et al: Subclinical neuropathy in lead workers. Br Med J 2:80, 1970.CrossRefGoogle Scholar
  40. 40.
    Cavalleri A, Baruffini A, Minola C, et al: Biological response of children to low levels of inorganic lead. Environ Res 25:415, 1981.PubMedCrossRefGoogle Scholar
  41. 41.
    Centers for Disease Control: Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control, Centers for Disease Control, Atlanta, 1991.Google Scholar
  42. 42.
    Centers for Disease Control: Leads from the MMWR. Serum 2,3,7,8-tetrachloride benzo-p-dioxin levels in Air Force health study participants, preliminary report. JAMA 259:3533, 1988.CrossRefGoogle Scholar
  43. 43.
    Centers for Disease Control: Serum 2,3,7,8-tetra-chlorodibenzo-p-dioxin levels in US Army Vietnam-era veterans. JAMA 260:1249, 1988.CrossRefGoogle Scholar
  44. 44.
    Chang KJ, Hsieh KH, Lee TP, et al: Immunologic evaluation of patients with polychlorinated biphenyl poisoning: Determination of lymphocyte subpopulations. Toxicol Appl Pharmacol 61:58, 1981.PubMedCrossRefGoogle Scholar
  45. 45.
    Chang KJ, Hsieh KH, Tang S, et al: Immunologic evaluation of patient with polychlorinated biphenyl poisoning: Evaluation of delayed-type skin hypersensitivity response and its relation to clinical studies: J Toxicol Environ Health 9:217, 1982.PubMedCrossRefGoogle Scholar
  46. 46.
    Chisolm JJ Jr: Lead poisoning. In: Pediatrics, 18th ed., p 732, Rudolph AM (ed.), Hoffman JIE (co-ed.), Axelrod S (asst. ed.), Appleton & Lange, Norwalk, Connecticut, 1987.Google Scholar
  47. 47.
    Chisolm JJ, O’Hara DM: Lead absorption in children—management, clinical and environmental aspects, Urban & Schwarzenberg, Baltimore, 1982.Google Scholar
  48. 48.
    Christofferson JO, Schütz A, Ahlgren L, et al: Lead in finger-bone analyzed in vivo in active and retired workers. Am J Ind Med 6:447, 1984.CrossRefGoogle Scholar
  49. 49.
    Clarkson TW, Greenwood MR: Mercury, biological specimen collections. In: The Use of Biological Specimens for the Assessment of Human Exposure to Environmental Pollutants, p 109, Berlin A, Wolff AH, Hasegawa Y (eds.), Martinus Nijhoff, The Hague, 1979.Google Scholar
  50. 50.
    Clarkson TW, Nordberg GF, Sager PR: Reproductive and Developmental Toxicity of Metals, Plenum Press, New York, 1983.CrossRefGoogle Scholar
  51. 51.
    Coggon D, Pannett B, Winter PC, et al: Mortality of workers exposed to 2-methyl-4-chlorophenoxyacetic acid. Scand J Work Environ Health 12:448, 1986.PubMedCrossRefGoogle Scholar
  52. 52.
    Colombi A, Maroni M, Ferioli A, et al: Increases in urinary porphyrin excretion in workers exposed to polychlorinated biphenyls. J Appl Toxicol 2:117, 1982.CrossRefGoogle Scholar
  53. 53.
    Committee on Biological Markers of the National Research Council: Biological Markers in Environmental Health Research. Environ Health Perspect 74:3, 1987.Google Scholar
  54. 54.
    Committee on Lead in the Human Environment, National Research Council: Lead in the Human Environment. National Academy of Sciences, Washington, 1980.Google Scholar
  55. 55.
    Council on Environmental Quality: Contamination of Ground Water by Toxic Organic Chemicals, US Government Printing Office, Washington, 1981.Google Scholar
  56. 56.
    Council on Scientific Affairs: The Health Effects of “Agent Orange” and Polychlorinated Dioxin Contaminants: An Update, 1984, American Medical Association, Chicago, 1984.Google Scholar
  57. 57.
    Courtney KD: Mouse teratology studies with chlo-rodibenzo-p-dioxins. Bull Environ Contam Toxicol 16:674, 1976.PubMedCrossRefGoogle Scholar
  58. 58.
    Coye MJ, Lowe JA, Maddy KT: Biological monitoring of agricultural workers exposed to pesticides I. Cholinesterase activity determinations. J Occup Med 28: 619, 1986.PubMedCrossRefGoogle Scholar
  59. 59.
    Coye MJ, Lowe JA, Maddy KT: Biological monitoring of agricultural workers exposed to pesticides. II. Monitoring of intact pesticides and their metabolites. J Occup Med 28:629, 1986Google Scholar
  60. 60.
    Crecelius EA: Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147, 1977.PubMedCrossRefGoogle Scholar
  61. 61.
    Dabney BJ: The role of human genetic monitoring in the workplace. J Occup Med 23:626, 1981.PubMedCrossRefGoogle Scholar
  62. 62.
    Dietrich KN, Krafft KM, Bornschein RL, et al: Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics 80:721, 1987.PubMedGoogle Scholar
  63. 63.
    Dubowski KM, Luke JL: Measurement of carboxy-hemoglobin and carbon monoxide in blood. Ann Clin Lab Sci 3:53, 1973.PubMedGoogle Scholar
  64. 64.
    Ehrenberg L: Risk assessment of ethylene oxide and other compounds. In: Assessing Chemical Mutagens: The Risk to Humans, Banbury Report 1, p 157, McElhen VK, Abrahamson S (eds.), Cold Spring Harbor Laboratory, New York, 1979.Google Scholar
  65. 65.
    Ehrenberg L: Covalent binding of genotoxic agents to proteins and nucleic acids. In: Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, p 107, Berlin A, Draper M, Hemminki K, et al. (eds.), International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  66. 66.
    Ehrenberg L, Hiesche KD, Osterman-Golkar S, et al: Evaluation of genetic risks of alkylating agents: Tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24:83, 1974.PubMedCrossRefGoogle Scholar
  67. 67.
    Ehrenberg L, Moustacchi E, Osterman-Golkar S, et al: Dosimetry of genotoxic agents and dose response relationship of their effects. Mutat Res 123:121, 1983.PubMedCrossRefGoogle Scholar
  68. 68.
    Ellis KJ, Morgan WD, Zauzi I, et al: Critical concentrations of cadmium in human renal cortex: Dose-effect studies in cadmium smelter workers. J Toxicol Environ Health 7:691, 1981.PubMedCrossRefGoogle Scholar
  69. 69.
    Ellman GL, Courtney KD, Andres V, et al: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88, 1961.PubMedCrossRefGoogle Scholar
  70. 70.
    Emmerson BT: Chronic lead nephropathy. Kidney Int 4:1, 1973.PubMedCrossRefGoogle Scholar
  71. 71.
    Emmett EA, Maroni M, Jeffery J, et al: Studies of transformer repair workers exposed to PCBs: II. Results of clinical laboratory investigations. Am J Ind Med 14:47, 1988.PubMedCrossRefGoogle Scholar
  72. 72.
    Environmental Quality: 16th Report, p 227, Council on Environmental Quality, Washington, DC, 1985.Google Scholar
  73. 73.
    Eriksson M, Hardell L, Berg NO, et al: Soft tissue sarcomas and exposure to chemical substances. A case referent study. Br J Ind Med 38:27, 1981.PubMedGoogle Scholar
  74. 74.
    Ertie T, Henschler D, Muller G: Metabolism of tri-chloroethylene in man. I. The significance of tri-chloroethanol in long-term exposure conditions. Arch Toxikol 29:171, 1972.CrossRefGoogle Scholar
  75. 75.
    Evans HJ: The role of human cytogenetics in study of mutagenesis and carcinogenesis. In: Genetic Toxicology of Environmental Chemicals. Part A: Basic Principles and Mechanisms of Action, p 41, Ramel C, Lambert B, Magnusson J (eds.), Alan R Liss, New York, 1986.Google Scholar
  76. 76.
    Evans HJ: What has been achieved with cytogenetic monitoring? In: Monitoring of Occupational Ge-notoxicants, p 3, Sorsa M, Norppa H (eds.), Alan R Liss, New York, 1986.Google Scholar
  77. 77.
    Evans HJ, O’Riordan ML: Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat Res 31:135, 1975.PubMedCrossRefGoogle Scholar
  78. 78.
    Evans HJ, Buckton KE, Hamilton GE, et al: Radiation-induced chromosome aberrations in nuclear dockyard workers. Nature 277:531, 1979.PubMedCrossRefGoogle Scholar
  79. 79.
    Fabricant JC, Legator MS: Etiology, role and detection of chromosome aberrations in man. J Occup Med 23:617, 1981.PubMedCrossRefGoogle Scholar
  80. 80.
    Falck K, Grohn P, Sorsa H, et al: Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1:1250, 1979.PubMedCrossRefGoogle Scholar
  81. 81.
    Falck FY, Fine LJ, Smith RG, et al: Metallothionein and occupational exposure to cadmium. Br J Ind Med 40:305, 1983.PubMedGoogle Scholar
  82. 82.
    Falck FY, Fine LJ, Smith RB, et al: Occupational cadmium exposure and renal status. Am J Ind Med 4: 541, 1983.PubMedCrossRefGoogle Scholar
  83. 83.
    Fao V, Emmett EA, Maroni M, et al. (eds.): Occupational and Environmental Chemical Hazards: Cellular and Biochemical Indices for Monitoring Toxicity, John Wiley & Sons, New York, 1987.Google Scholar
  84. 84.
    Feldman RG, Niles CA, Kelly-Hayes M, et al: Peripheral neuropathy in arsenic smelter workers. Neurology 29:939, 1979.PubMedCrossRefGoogle Scholar
  85. 85.
    Fernandez JG, Humbert BE, Droz PO, et al: Exposition au trichloroethylene. Bilan de l’absorption, de l’excretion et du metabolisme sur des sujets humains. Arch Mal Prof Med Trav Securite Soc (Paris) 36:397, 1975.Google Scholar
  86. 86.
    Fishbeck WA, Langner RR, Kociba RJ: Elevated urinary phenol levels not related to benzene exposure. Am Ind Hyg Assoc J 36:820, 1975.PubMedCrossRefGoogle Scholar
  87. 87.
    Fitzgerald EF, Standfast SJ, Youngblood LG, et al: Assessing the health effects of potential exposure to PCBs, dioxins, and furans from electrical transformer fires: The Binghamton State Office Building Medical Surveillance Program. Arch Environ Health 41:368, 1986.PubMedCrossRefGoogle Scholar
  88. 88.
    Forni A: Chromosomal aberrations in monitoring exposure to mutagens-carcinogens. In: Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, p 325, Berlin A, Draper M, Hemminki K, et al. (eds.), International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  89. 89.
    Franklin CA, Fenske RA, Greenhalgh R, et al: Correlation of urinary pesticide metabolite excretion with estimated dermal contact in the course of occupational exposure to guthion. J Toxicol Environ Health 7:715, 1981.PubMedCrossRefGoogle Scholar
  90. 90.
    Friberg L: Cadmium. Annu Rev Public Health 4:367, 1983.CrossRefGoogle Scholar
  91. 91.
    Gadoth N, Fisher A: Late onset of neuromuscular block in organophosphate poisoning. Ann Intern Med 88:654, 1978.PubMedCrossRefGoogle Scholar
  92. 92.
    Garner RC: Assessment of carcinogen exposure in man. Carcinogenesis 6:1071, 1985.PubMedCrossRefGoogle Scholar
  93. 93.
    Garner RC, Mould AJ, Lindsay-Smith V, et al: Mutagenic urine from bladder cancer patients. Lancet 2: 398, 1982.Google Scholar
  94. 94.
    Gebhart E: Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Hum Genet 58:235, 1981.PubMedCrossRefGoogle Scholar
  95. 95.
    Gehring PJ, Dramer CG, Schwetz BA, et al: The fate of 2,4,5-trichlorophenoxyacetic acid following oral administration to man. Toxicol Appl Pharmacol 26: 352, 1973.PubMedCrossRefGoogle Scholar
  96. 96.
    Gershon S, Shaw FB: Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1:1371, 1961.PubMedCrossRefGoogle Scholar
  97. 97.
    Goldstein IF: The use of biological markers in studies of health effects of pollutants. Environ Res 25:236, 1981.PubMedCrossRefGoogle Scholar
  98. 98.
    Gottschling LM, Beaulieu HJ, Melvin WW: Monitoring of formic acid in urine of humans exposed to low levels of formaldehyde. Am Ind Hyg Assoc 45:19, 1984.CrossRefGoogle Scholar
  99. 99.
    Green LC, Skipper PI, Turesky RJ, et al: In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res 44:4254, 1984.PubMedGoogle Scholar
  100. 100.
    Hammond PB, Lerner SI, Gartside PS, et al: The relationship of biological indices of lead exposure to the health status of workers in a secondary lead smelter. J Occup Med 22:475, 1980.PubMedGoogle Scholar
  101. 101.
    Hardell L, Eriksson M: The association between soft-tissue sarcomas and exposure to phenoxyacetic acids. Cancer 62:652, 1988.PubMedCrossRefGoogle Scholar
  102. 102.
    Hardell L, Sandstrom A: Case-control study: Soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols. Br J Cancer 39:711, 1979.PubMedCrossRefGoogle Scholar
  103. 103.
    Hardell L, Eriksson M, Lenner P: Malignant lymphoma and exposure to chemicals, especially organic solvent, chlorophenols and phenoxyacids: A case control study. Br J Cancer 43:169, 1981.PubMedCrossRefGoogle Scholar
  104. 104.
    Harris CC, Vahakangas K, Newman MJ, et al: Detection of benzo(a)pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 82:6672, 1985.PubMedCrossRefGoogle Scholar
  105. 105.
    Hartwell TC, et al: Study of Carbon Monoxide Exposure of Residents of Washington, DC and Denver, CO Prepared for US Environmental Protection Agency, Environmental Monitoring Systems Laboratory, Research Triangle Park, NC, 1984.Google Scholar
  106. 106.
    Hayes WJ Jr: Pesticide Studies in Man, Williams & Wilkins, Baltimore, 1982.Google Scholar
  107. 107.
    Heddle JA, Blakey DH, Duncan AMV, et al: Micro-nuclei and related nuclear anomalies as a short-term assay for colon carcinogens. In: Indicators of Geno-toxic Exposure, Banbury Report 13, p 367, Bridges BA, Butterworth BE, Weinstein IB (eds.), Cold Spring Harbor Laboratory, New York, 1982.Google Scholar
  108. 108.
    Heddle JA, Hite M, Kirkhart B, et al: The induction of micronuclei as a measure of genotoxicity. Mutat Res 123:61, 1983.PubMedCrossRefGoogle Scholar
  109. 109.
    Hemminki K, Randerath K: Detection of genetic interaction of chemicals by biochemical methods: Determination of DNA and protein adducts. In: Mechanisms of Cell Injury: Implications for Human Health, p 209, Fowler BA (ed.), John Wiley & Sons, New York, 1987.Google Scholar
  110. 110.
    Hernberg S, Nakkanen J, Mellin G, et al: γ-Aminolevulinic acid dehydrase as a measure of lead exposure. Arch Environ Health 21:140, 1970.PubMedCrossRefGoogle Scholar
  111. 111.
    Hindmarsh JT, McLetchie OR, Leroy MD, et al. Electromyographic abnormalities in chronic environmental arsenicalism. J Anal Toxicol 1:270, 1977.CrossRefGoogle Scholar
  112. 112.
    Hoar SK, Blair A, Holmes FF, et al: Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma JAMA 256:1141, 1986.Google Scholar
  113. 113.
    Hulka BS, Wilcosky TC, Griffith JD: Biological Markers in Epidemiology, Oxford University Press, 1990.Google Scholar
  114. 114.
    International Agency for Research on Cancer: Benzene. In: Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol 29, Some Chemicals and Dyestuffs, p 93, IARC, Lyon, 1982.Google Scholar
  115. 115.
    International Agency for Research on Cancer: Monographs on the Evaluation of Carcinogenic Risk to Humans, Suppl 7, Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Vol 1–42, IARC, Lyon, 1987.Google Scholar
  116. 116.
    Ikeda M, Otsumi H, Imamura T, et al: Urinary excretion of total trichloro compounds, trichloroethanol, and trichloroacetic acid as a measure of exposure to trichloroethylene and tetrachloroethylene. Br J Ind Med 29:328, 1972.PubMedGoogle Scholar
  117. 117.
    Jabara JW, Baaulieu HJ, Buchan RM, et al: Carbon monoxide: Dosimetry in occupational exposures in Denver, Colorado. Arch Environ Health 35:198, 1980.PubMedGoogle Scholar
  118. 118.
    Jeffery AM, Weinstein IB, Jennette KW, et al: Structures of benzo(a)pyrene-nucleic acid adducts formed in human and bovine bronchial expiants. Nature 269: 348, 1977.CrossRefGoogle Scholar
  119. 119.
    Jensen AA: Chemical contaminants in human milk. Residue Rev 89:1, 1983.PubMedCrossRefGoogle Scholar
  120. 120.
    Jensen S, Sundstrom G: Structure and levels of most chlorobiphenyls in two technical PCB products and in human adipose tissue. Ambio 3:70, 1974.Google Scholar
  121. 121.
    Jirasek L, Kalensky J, Kubec K, et al: Chloracne, porphyria cutanea tarda and other manifestations of general poisonings during the manufacture of herbicides. Cesk Dermatol 49:145, 1974.PubMedGoogle Scholar
  122. 122.
    Johnson BL (ed.): Prevention of Neurotoxic Illness in Working Populations, John Wiley & Sons, New York, 1987.Google Scholar
  123. 123.
    Johnson MK: Mechanism of protection against delayed neurotoxic effects of organophosphorous ester. Fed Proc 31:73, 1976.Google Scholar
  124. 124.
    Kahn PC, Gochfeld M, Nygren M, et al: Dioxins and dibenzofurans in blood and adipose tissue of Agent Orange-exposed Vietnam veterans and matched controls. JAMA 259:1661, 1988.PubMedCrossRefGoogle Scholar
  125. 125.
    Kerns WD, Pavkov KL, Donofrio DJ, et al: Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 43:4582, 1983.Google Scholar
  126. 126.
    Khan MAQ, Stanton RH (eds.): Toxicology of Halo-genated Hydrocarbons: Health and Ecological Effects, p 38, Pergamon Press, New York, 1981.Google Scholar
  127. 127.
    Kiihimäki V, Asp S, Pukkala E, et al: Mortality and cancer morbidity among chlorinated phenoxyacid applicators in Finland. Chemosphere 12:779, 1983.CrossRefGoogle Scholar
  128. 128.
    Kimbrough RD: The toxicity of polychlorinated poly-cyclic compounds and related compounds. CRC Crit Rev Toxicol 2:445, 1974.PubMedCrossRefGoogle Scholar
  129. 129.
    Kimbrough RD, Jensen AA (eds.): Halogenated Biphenyls, Terphenyls, Naphthalene, Dibenzodioxins and Related Products, 2nd Ed., Elsevier/North Holland, Amsterdam, 1989.Google Scholar
  130. 130.
    Kimbrough RD; Human health effects of polychlorinated biphenyls (PCBs) and polybrominated bi-phenyls (PBBs). Annu Rev Pharmacol Toxicol 27:87, 1987.PubMedCrossRefGoogle Scholar
  131. 131.
    Kimbrough RD, Carter CD, Liddle JA, et al: Epidemiology and pathology of a tetrachlorodibenzodioxin poisoning episode. Arch Environ Health 32:77, 1977.PubMedCrossRefGoogle Scholar
  132. 132.
    Kolmodin-Hedman G, Höglund S, Âkerblom M: Studies on phenoxyacid herbicides. 1. Field study: Occupational exposure to phenoxyacid herbicides (MCPA, dichlorprop, mecroprop, and 2,4-D) in agriculture. Arch Toxicol 54:257, 1983.PubMedCrossRefGoogle Scholar
  133. 133.
    Kreiss K: Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect 60: 193, 1985.PubMedCrossRefGoogle Scholar
  134. 134.
    Kreiss K, Zack MM, Kimbrough RD, et al: Association of blood pressure and polychlorinated biphenyl levels. JAMA 245:2505, 1981.PubMedCrossRefGoogle Scholar
  135. 135.
    Kreiss K, Zack MM, Kimbrough RD, et al: Cross-sectional study of a community with exceptional exposure to DDT. JAMA 245:926, 1981.Google Scholar
  136. 136.
    Kreiss K, Zach MM, Landrigan PJ, et al: Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health 38:116, 1983.PubMedCrossRefGoogle Scholar
  137. 137.
    Kuratsume M, Shapiro RE (eds.): PCB Poisoning in Japan and Taiwan, Alan R Liss, New York, 1984.Google Scholar
  138. 138.
    Kutz FW, Yobs AR, Strassman SC, et al: Effects of reducing DDT usage on total DDT storage in humans. Pesticide Monit J 11:61, 1977.Google Scholar
  139. 139.
    Lambert B, Lindblad A, Homberg E, et al: The use of sister chromatid exchange to monitor human populations for exposure to toxicologically harmful agents. In: Sister Chromatid Exchange, p 149, Wolff S (ed.), John Wiley & Sons, New York, 1982.Google Scholar
  140. 140.
    Lancranjan I, Popescu HI, Gavanescu O, et al: Reproductive ability of workman occupationally exposed to lead. Arch Environ Health 30:396, 1975.PubMedCrossRefGoogle Scholar
  141. 141.
    Langolf GD, Chaffin R, Henderson R, et al: Evaluation of workers exposed to elemental mercury using quantitative tests of tremor and neuromuscular functions. Am Ind Hyg Assoc J 39:976, 1978.PubMedCrossRefGoogle Scholar
  142. 142.
    Laskin S, Goldstein BD (eds.): Benzene toxicity: A critical evaluation. Toxicol Environ Health 2(Suppl): 1977.Google Scholar
  143. 143.
    Laties VG, Merigan WH: Behavioral effects of carbon monoxide on animals and man. Annu Rev Pharmacol Toxicol 19:357, 1979.PubMedCrossRefGoogle Scholar
  144. 144.
    Lauwerys R: Biological criteria for selected industrial toxic chemicals: A review. Scand J Work Environ Health 1:139, 1975.PubMedCrossRefGoogle Scholar
  145. 145.
    Lauwerys RR: Industrial Chemical Exposure— Guidelines for Biological Monitoring, Biomedical Publications, Davis, CA, 1983.Google Scholar
  146. 146.
    Lauwerys RR: In vivo tests to monitor body burdens of toxic metals in man. In: Chemical Toxicology and Clinical Chemistry of Metals, p 113, Brown SS, Savory J (eds.), Academic Press, Orlando, 1983.Google Scholar
  147. 147.
    Lauwerys R: Basic concepts of monitoring human exposure. In: Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, p 31, Berlin A, Draper M, Kernminki K, et al. (eds.), International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  148. 148.
    Lauwerys R, Roels H, Regniers M, et al: Significance of cadmium concentration in blood and in urine in workers exposed to cadmium. Environ Res 20:375, 1979.PubMedCrossRefGoogle Scholar
  149. 149.
    Laws ER, Curley A, Biros FJ: Men with intensive occupational exposure to DDT. Arch Environ Health 15:766, 1967.PubMedCrossRefGoogle Scholar
  150. 150.
    Lewalter J, Koralius U: Erythrocyte protein conjugates as a principle of biological monitoring for pesticides. Toxicol Lett 33:153, 1986.PubMedCrossRefGoogle Scholar
  151. 151.
    Lindstedt G: Individual mercury exposure of chlor-alkali workers and its relation to blood and urinary mercury levels. Scand J Work Environ Health 5:59, 1979.PubMedCrossRefGoogle Scholar
  152. 152.
    Lloyd DC: An overview of radiation dosimetry by conventional cytogenetic methods. In: Biological Dosimetry, p 3, Eisert WG, Mendelsohn ML (eds.), Springer-Verlag, Berlin, 1984.CrossRefGoogle Scholar
  153. 153.
    Lohman PHM, Jansen JD, Baan RA: Comparison of various methodologies with respect to specificity and sensitivity in biomonitoring occupational exposure to mutagens and carcinogens. In: Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, p 259, Berlin A, Draper M, Hemminki K, et al. (eds.), International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  154. 154.
    Lohman PHM, Lauwerys R, Sorsa M: Overview: Methods of monitoring human exposure to carcinogenic and mutagenic agents. In: Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, p 423, Berlin A, Draper M, Hemminki K, et al. (eds.), International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  155. 155.
    Lores EM, Bradway DE, Moseman RF: Organophos-phorus pesticide poisonings in humans: Determination of residues and metabolites in tissues and urine. Arch Environ Health 33:270, 1978.PubMedCrossRefGoogle Scholar
  156. 156.
    Lutz WK: In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat Res 65:289, 1979.PubMedCrossRefGoogle Scholar
  157. 157.
    Lynge E: A follow-up study of cancer incidence among workers in manufacture of phenoxy herbicides in Denmark. Br J Cancer 52:259, 1985.PubMedCrossRefGoogle Scholar
  158. 158.
    Magos L: Biological methods of defining human exposures. In: Health Effects from Hazardous Waste Sites, p 122, Andelman JB, Underhill DW (eds.), Lewis Publishers, Boca Raton, 1987.Google Scholar
  159. 159.
    Mahaffey KR, Annest JL, Roberts MS, et al: National estimates of blood lead levels. United States 1976–1980. N Engl J Med 307:573, 1982.PubMedCrossRefGoogle Scholar
  160. 160.
    Mahaffey KR, Annest JL, Roberts MS, et al: Association between age, blood lead concentration and serum 1,25-dihydroxycholecaliferol levels in children. Am J Clin Nutr 35:1327, 1982.PubMedGoogle Scholar
  161. 161.
    Mahieu P, Buchet JP, Roels HA, et al: The metabolism of arsenic in humans acutely intoxicated by AsO3. Its significance for the duration of BAL therapy. Clin Toxicol 18:1067, 1981.PubMedCrossRefGoogle Scholar
  162. 162.
    Masuda Y, Kuroki H, Karaguchi K, et al: PCB and PCDF congeners in the blood and tissues of yusho and yu-cheng patients. Environ Health Perspect 59: 53, 1985.PubMedCrossRefGoogle Scholar
  163. 163.
    Matthews HB, Dedrick RL: Pharmacokinetics of PCBs. Annu Rev Pharmacol Toxicol 24:85, 1984.PubMedCrossRefGoogle Scholar
  164. 164.
    Mattson AM, Sedlak VA: Ether-extractable urinary phosphates in man and rats derived from malathion and similar compounds. J Agr Food Chem 8:107, 1960.CrossRefGoogle Scholar
  165. 165.
    McConnell EE: Comparative toxicity of PCBs and related compounds in various species of animals. Environ Health Perspect 60:29, 1985.PubMedCrossRefGoogle Scholar
  166. 166.
    McCoy EC, Hankel R, Robins R, et al: Presence of mutagenic substances in the urines of anesthesiologists. Mutat Res 53:71, 1978.Google Scholar
  167. 167.
    McMichael AJ, Baghurst PA, Wigg NR, et al: Port Pirie cohort study: Environmental exposure to lead and children’s abilities at the age of four years. N Engl J Med 319:468, 1988.PubMedCrossRefGoogle Scholar
  168. 168.
    Metcalf DR, Holmes JH: EEG, psychological and neurological alterations in humans with organo-phosphate exposure. Ann NY Acad Sci 160:357, 1969.PubMedCrossRefGoogle Scholar
  169. 169.
    Meyer B: Indoor Air Quality, Addison-Wesley, Reading, MA, 1983.Google Scholar
  170. 170.
    Michel HO: An electrometric method for the determination of red blood cell and plasma Cholinesterase activity. J Lab Clin Med 34:1564, 1949.Google Scholar
  171. 171.
    Miller EC, Miller JA: Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules. Pharmacol Rev 18: 805, 1966.PubMedGoogle Scholar
  172. 172.
    Miller EC, Miller JA: Mechanisms of chemical carcinogenesis. Cancer 47:1055, 1981.PubMedCrossRefGoogle Scholar
  173. 173.
    Miller JA, Miller EC: Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Origins of Human Cancer, p 605, Hiatt HH, Watson JD, Winsten AA (eds.), Cold Spring Harbor Laboratory, New York, 1977.Google Scholar
  174. 174.
    Milman HA, Sell S (eds.): Application of Biological Markers to Carcinogen Testing, Plenum Press, New York, 1982.Google Scholar
  175. 175.
    Morbidity and Mortality Weekly Report: Childhood lead poisoning—United States: Report to the Congress by the Agency for Toxic Substances and Disease Registry. Morbid Mortal Week Rep 37(32):461, 1988.Google Scholar
  176. 176.
    Monster AC, Boersma G, Duba WC: Kinetics of tri-chloroethylene in repeated exposure of volunteers. Int Arch Occup Environ Health 42:283, 1979.PubMedCrossRefGoogle Scholar
  177. 177.
    Montesano R, Bartsch H, Vainio H, et al: Long-Term and Short-Term Assays for Carcinogens: A Critical Appraisal, IARC Scientific Publication no. 83, International Agency for Research on Cancer, Lyon, 1986.Google Scholar
  178. 178.
    Morgan DP: Recognition and Management of Pesticide Poisonings, 4th Ed., EPA-540/9–88-001 US EPA, Washington, 1989.Google Scholar
  179. 179.
    Morgan DP, Hetzler HL, Sclach EE, et al: Urinary excretion of paranitrophenol and alkylphosphates following ingestion of methyl or ethyl parathion by human subjects. Arch Environ Contam Toxicol 6:153, 1977.CrossRefGoogle Scholar
  180. 180.
    Muller G, Spassovski M, Henschler D: Irichloro-ethylene exposure and trichloroethylene metabolites in urine and blood. Arch Toxikol 29:335, 1972.PubMedCrossRefGoogle Scholar
  181. 181.
    Müuller G, Spassovski M, Henschler D: Metabolism of trichloroethylene in man. II. Pharmacokinetics of metabolites. Arch Toxicol 32:283, 1974.CrossRefGoogle Scholar
  182. 182.
    Murphy RS, Kutz FW, Strassman SC: Selected pesticide residues or metabolites in blood and urine. Specimens from a general population survey. Environ Health Perspect 48:81, 1983.PubMedCrossRefGoogle Scholar
  183. 183.
    Murthy MSS, Calleman CJ, Osterman-Golkar S, et al: Relationships between ethylation of hemoglobin, ethylation of DNA and administered amount of ethyl methanesulfonate in the mouse. Mutat Res 127:1, 1984.PubMedCrossRefGoogle Scholar
  184. 184.
    National Institute of Occupational Safety and Health: Criteria for Recommended Standard Occupational Exposure to Inorganic Lead. Revised Criteria, US DHEW (NIOSH), Pub #78–158, Washington, 1978.Google Scholar
  185. 185.
    Needleman HL: Low level lead exposure in the fetus and young child. Neurotoxicology 8:389, 1987.PubMedGoogle Scholar
  186. 186.
    Needleman HL, Tuncay O, Shapiro IM: Lead levels in deciduous teeth of urban and suburban children. Nature 235:111, 1972.PubMedCrossRefGoogle Scholar
  187. 187.
    Needleman HL, Gunnoe C, Leviton A, et al: Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 300:689, 1979.PubMedCrossRefGoogle Scholar
  188. 188.
    Neubert D, Dillmann I: Embryotoxic effects on mice treated with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Pharmacol 272:243, 1972.CrossRefGoogle Scholar
  189. 189.
    Neumann HG: Dose-response relationship in the primary lesion of strong electrophilic carcinogens. Arch Toxicol 3 (Suppl):69, 1980.CrossRefGoogle Scholar
  190. 190.
    Neumann HG: Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Arch Toxicol 56:1, 1984.PubMedCrossRefGoogle Scholar
  191. 191.
    Newmann HG: Concepts for assessing the internal dose of chemicals in vivo. In: Mechanisms of Cell Injury: Implications for Human Health, p 241, Fowler BA (ed.), John Wiley & Sons, New York, 1987.Google Scholar
  192. 192.
    Norbach DH, Weltman RH: Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ Health Perspect 60:97, 1985.CrossRefGoogle Scholar
  193. 193.
    Osterloh J, Kaysen G, Becker C: Handling of formalin in dialysis units. Transplant Dialysis 12:353, 1983.Google Scholar
  194. 194.
    Osterloh J, Lotti M, Pond SM: Toxicological studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos. J Anal Toxicol 7:125, 1983.PubMedCrossRefGoogle Scholar
  195. 195.
    Osterloh J, Cone J, Harrison R, et al: Pilot survey of urinary porphyrin from persons transiently exposed to a PCB transformer fire. J Toxicol Clin Toxicol 24: 533, 1987.CrossRefGoogle Scholar
  196. 196.
    Osterman-Golkar S, Ehrenberg L: Dosimetry of elec-trophilic compounds by means of hemoglobin alkyl-ation. Annu Rev Public Health 4:397, 1983.PubMedCrossRefGoogle Scholar
  197. 197.
    Osterman-Golkar S, Ehrenberg L, Segerbäch D, et al: Evaluation of genetic risks of alkylating agents II. Haemoglobin as a dose monitor. Mutat Res 34:1, 1976.PubMedCrossRefGoogle Scholar
  198. 198.
    Otto D, Robinson G, Baumann S, et al: 5-year follow-up study of children with low-to-moderate lead absorption: Electrophysiological evaluation. Environ Res 38:168, 1985.PubMedCrossRefGoogle Scholar
  199. 199.
    Park DV, Williams RT: Studies in detoxication. The metabolism of benzene containing 14C. Biochem J 54: 231, 1953.Google Scholar
  200. 200.
    Patterson DG Jr, Hampton L, Lapeza CR Jr, et al: High-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Anal Chem 59: 2000, 1987.Google Scholar
  201. 201.
    Patterson DG Jr, Needham LL, Pirkle JL, et al: Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri. Arch Environ Contam Toxicol 17:139, 1988.PubMedCrossRefGoogle Scholar
  202. 202.
    Perbellini L, Faccini GB, Pasini F, et al: Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med 45:345, 1988.PubMedGoogle Scholar
  203. 203.
    Perera F: Molecular epidemiology: A novel approach to the investigation of pollutant-related chronic disease. In: Environmental Impacts on Human Health: Agenda for Long-Term Research and Development, p 61, Draggan S, Cohrssen JJ, Morrison RE (eds.), Praeger, London, 1987.Google Scholar
  204. 204.
    Perera FP: Molecular cancer epidemiology: A new tool in cancer prevention. J Natl Cancer Inst 78:887, 1987.PubMedGoogle Scholar
  205. 205.
    Perera FP: The significance of DNA and protein ad-ducts in human biomonitoring studies. Mutat Res 205:255, 1988.PubMedCrossRefGoogle Scholar
  206. 206.
    Perera F, Weinstein IB: Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation. J Chron Dis 35: 581, 1982.PubMedCrossRefGoogle Scholar
  207. 207.
    Perera F, Santella RM, Brenner D, et al: DNA adducts, protein adducts, and sister chromatic exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst 79:449, 1987.PubMedGoogle Scholar
  208. 208.
    Periera MA, Chang LW: Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem Biol Interact 33:301, 1981.CrossRefGoogle Scholar
  209. 209.
    Perry HM, Gurdarsham S, Thind MD, et al: The biology of cadmium. Symposium on Trace Elements. Med Clin North Am 60:759, 1976.PubMedGoogle Scholar
  210. 210.
    Perry P, Wolff S: New Giemsa method for differential staining of sister chromatids. Nature 261:156 1974.CrossRefGoogle Scholar
  211. 211.
    Piomelli S, Seamen C, Zullow D, et al: Threshold for lead damage to heme synthesis in urban children. Proc Natl Acad Sci USA 79:3335, 1982.PubMedCrossRefGoogle Scholar
  212. 212.
    Piotrowski JK: Exposure Tests for Organic Compounds in Industrial Toxicology, US Government Printing Office, Washington, 1977.Google Scholar
  213. 213.
    Pirkle JL, Wolfe WH, Patterson DG Jr, et al: Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Ranch Hand veterans. Presented at the Seventh International Symposium on Clorinated Dioxins and Related Compounds, Las Vegas, Nevada, October 7, 1987.Google Scholar
  214. 214.
    Pocchiari F, Silano V, Zamplieri A: Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann NY Acad Sci 275:311, 1979.Google Scholar
  215. 215.
    Poirier MC: Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst 67:515, 1981.PubMedGoogle Scholar
  216. 216.
    Poirier MC, Stanley JR, Beckwith JB, et al: Indirect immunofluorescent localization of benzo(a)pyrene adducts to nucleic acids in cultured mouse keratino-cyte nuclei. Carcinogenesis 3:345, 1982.PubMedCrossRefGoogle Scholar
  217. 217.
    Putoni R, Merio F, Fini A, et al: Soft-tissue sarcomas in Seveso. Lancet 2:525, 1986.CrossRefGoogle Scholar
  218. 218.
    Rabinowitz MB, Wetherill GW, Kopple JM: Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58:260, 1976.PubMedCrossRefGoogle Scholar
  219. 219.
    Ramsey JC, Hefner JG, Karbowski RJ, et al: The in-vivo biotransformation of 2,3,7,8-tetrachlorordibenzo-p-dioxin in the rat. Toxicol Appl Pharmacol) 48(1) (part2:A162, 1979.Google Scholar
  220. 220.
    Reddy MV, Gupta RC, Randerath EV, et al: 32P. Postlabelling test for covalent DNA binding of aromatic carcinogens and methylating agents. Carcinogenesis 5:231, 1984.PubMedCrossRefGoogle Scholar
  221. 221.
    Reed E, Yuspa SH, Swelling LA, et al: Quantitation of cis-diaminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cis-platin chemotherapy. J Clin Invest 77:545, 1986.PubMedCrossRefGoogle Scholar
  222. 222.
    Reid SJ, Watts RR: A method for the determination of dialkylphosphate residues in urine. J Anal Toxicol 5: 1264, 1981.CrossRefGoogle Scholar
  223. 223.
    Report of the Federal Panel on Formaldehyde: Environ Health Perspect 43:139, 1982.CrossRefGoogle Scholar
  224. 224.
    Rider JA, Hodges JL, Swader J, et al: Plasma and red cell Cholinesterase in 800 “healthy” blood donors. J Lab Clin Med 50:376, 1957.PubMedGoogle Scholar
  225. 225.
    Rinsky RA, Young RJ, Smith AB: Leukemia in benzene workers. Am J Ind Med 2:217, 1981.PubMedCrossRefGoogle Scholar
  226. 226.
    Roels H, Bernard A, Buchet JP, et al: Critical concentration of cadmium in renal cortex and urine. Lancet 1:221, 1979.PubMedCrossRefGoogle Scholar
  227. 227.
    Roels HA, Lauwerys RR, Buchet JP, et al: In vivo measurement of liver and kidney cadmium in workers exposed to this metal: Its significance with respect to cadmium in blood and urine. Environ Res 26:217, 1981.PubMedCrossRefGoogle Scholar
  228. 228.
    Roels H, Lauwery R, Buchet JP, et al: Comparison of renal function and psychomotor performance in workers exposed to elemental mercury. Int Arch Oc-cup Environ Health 50:77, 1982.CrossRefGoogle Scholar
  229. 229.
    Rogan WJ: Persistent pesticides and polychlorinated biphenyls. Annu Rev Public Health 4:381, 1983.PubMedCrossRefGoogle Scholar
  230. 230.
    Rogan WJ, Bagniewski A, Damstra T: Pollutants in breast milk. N Engl J Med 302:1450, 1980.PubMedCrossRefGoogle Scholar
  231. 231.
    Rogan WJ, Gladen BC, Hung KL, et al: Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241:334, 1988.PubMedCrossRefGoogle Scholar
  232. 232.
    Rose JQ, Ramsey JC, Wentzler TH, et al: The fate of TCDD following single and repeated oral doses to the rat. Toxicol Appl Pharmacol 36:209, 1976.PubMedCrossRefGoogle Scholar
  233. 233.
    Roush GJ, Ott MG: A study of benzene exposure versus urinary phenol levels. Am Ind Hyg Assoc J 38: 67, 1977.PubMedCrossRefGoogle Scholar
  234. 234.
    Safe Drinking Water Committee, National Research Council: Drinking Water and Health, National Academy of Sciences, Washington, 1977.Google Scholar
  235. 235.
    Sarma PR, Jacobs J: Thoracic soft-tissue sarcoma in Vietnam veterans exposed to Agent Orange. N Engl J Med 306:1109, 1982.PubMedGoogle Scholar
  236. 236.
    Sauerhoff MW, Braun WH, Blau GE, et al: The fate of 2,4-dichlorophenoxyacetic acid (2,4-D) following oral administration to man. Toxicology 8:3, 1977.PubMedCrossRefGoogle Scholar
  237. 237.
    Schwartz PM, Jacobson SW, Fein GG, et al: Lake Michigan fish consumption as a source of polychlorinated biphenyls in human cord serum, maternal serum and milk. Am J Public Health 73:293, 1983.PubMedCrossRefGoogle Scholar
  238. 238.
    Seppäläinen Am, Hernberg SA: A follow-up study of nerve conduction velocities in lead exposed workers. Neurobehav Toxicol Teratol 4:721, 1982.Google Scholar
  239. 239.
    Seppäläinen AM, Tola S, Hernberg S, et al: Subclinical neuropathy at “safe” levels of lead exposure. Arch Environ Health 30:180, 1975.PubMedCrossRefGoogle Scholar
  240. 240.
    Seppäläinen AM, Hernberg S, Vesanto R, et al: Early neurotoxic effects of occupational lead exposure: A prospective study. Neurotoxicology 4:181, 1983.PubMedGoogle Scholar
  241. 241.
    Shafik T, Bradway DE, Enos HF, et al: Human exposure to organophosphate pesticides. A modified procedure for gas liquid chromatographic analysis of alkyl phosphate metabolites in urine. J Agr Food Chem 21:625, 1973.CrossRefGoogle Scholar
  242. 242.
    Shaikh ZA, Tohyama C: Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Per-spect 54:171, 1984.CrossRefGoogle Scholar
  243. 243.
    Sharp DS, Eskenazi B, Harrison R, et al: Delayed health hazards of pesticide exposure. Annu Rev Public Health 7:441, 1986.PubMedCrossRefGoogle Scholar
  244. 244.
    Sheldon L, Umana M, Bursey J, et al: Biological Monitoring Techniques for Human Exposure to Industrial Chemicals: Analysis of Human Fat, Skin, Nails, Hair, Blood, Urine, and Breath, Noyes Publications, Park Ridge, New Jersey, 1986.Google Scholar
  245. 245.
    Silbergeld EK: Exposures: Uptake, tissue and target dose. In: Mechanisms of Cell Injury: Implications for Human Health, p 405, Fowler BA (ed.), John Wiley & Sons, New York, 1987.Google Scholar
  246. 246.
    Singer R, Valciukas JA, Luis R: Lead exposure and nerve conduction velocity: The differential time course of sensory and motor nerve effects. Neurotoxicology 4:193, 1983.PubMedGoogle Scholar
  247. 247.
    Sipes IG, Slocum ML, Perry DF, et al: 2,4,5,2′,4′,5′-Hexachlorobiphenyl: Distribution, metabolism and excretion in the dog and the monkey. Toxicol Appl Pharmacol 65:264, 1982.PubMedCrossRefGoogle Scholar
  248. 248.
    Slaga TJ, Fischer SM, Weeks CE, et al: Studies on the mechanism involved in multistage carcinogenesis in mouse skin. In: Mechanisms of Chemical Carcinogenesis, p 207, Harris CC, Cerutti PA (eds.), Alan R Liss, New York, 1983.Google Scholar
  249. 249.
    Smith LM, Stalling DL, Johnson JL: Determination of part-per-trillion levels of polychlorinated dibenzo-furans and dioxins in environmental samples. Anal Chem 56:1830, 1984.PubMedCrossRefGoogle Scholar
  250. 250.
    Smith M: Recent work on low level lead exposure and its impact on behavior, intelligence and learning: A review. J Am Acad Child Psychiatry 24:24, 1985.PubMedCrossRefGoogle Scholar
  251. 251.
    Snyder R, Longacre SL, Witmer CM, et al: Biochemical toxicology of benzene. (Revised) Biochem Toxicol 3:132, 1981.Google Scholar
  252. 252.
    Sorsa M: Sister chromatid exchange and micronuclei as monitoring methods. In: Monitoring of Human Exposure to Carcinogenic and Mutagenic Agents, p 339, Berlin A, Draper M, Hemminki K, et al. (eds.), International Agency for Research in Cancer, Lyon, 1984.Google Scholar
  253. 253.
    Sorsa M: Occupational genotoxicology. In: Occupational Medicine Principles and Practical Applications, p 806, Zenz C (ed.), Year Book Medical Publishers, Chicago, 1988.Google Scholar
  254. 254.
    Sorsa M, Norppa H (eds.): Monitoring of Occupational Genotoxicants, Alan R Liss, New York, 1986.Google Scholar
  255. 255.
    Sorsa M, Kemminki K, Vainio H: Biological monitoring of exposure to chemical mutagens in the occupational environment. Teratogen Carcinogen Mutagen 2:137, 1982.CrossRefGoogle Scholar
  256. 256.
    Spivey GH: Subclinical effects of chronic increased lead absorption: A prospective study. J Occup Med 22:607, 1980.PubMedGoogle Scholar
  257. 257.
    State of the Environment: A View Toward the Nineties, p 135, The Conservation Foundation, Washington, DC, 1987.Google Scholar
  258. 258.
    Stetka DG, Wolff S: Sister chromatid exchange as an assay for genetic damage induced by mutagen-carcinogens. I. In vivo test for compounds requiring metabolic activation. Mutat Res 41:333, 1976.Google Scholar
  259. 259.
    Stewart RD: The effect of carbon monoxide on humans. Annu Rev Pharmacol 15:409, 1975.PubMedCrossRefGoogle Scholar
  260. 260.
    Stewart RD, Dodd HC, Gay HH, et al: Experimental human exposure to trichloroethylene. Arch Environ Health 20:64, 1970.PubMedCrossRefGoogle Scholar
  261. 261.
    Stewart RD, Fisher TN, Hosko MJ, et al: Experimental human exposure to methylene chloride. Arch Environ Health 25:342, 1972.PubMedCrossRefGoogle Scholar
  262. 262.
    Strassman SC, Kutz FW: Trends of organochlorine pesticide residues in human tissues. In: Toxicology of Halogenated Hydrocarbons, p 38, Khan MAQ, Stanton RH (eds.), Pergamon Press, New York, 1981.Google Scholar
  263. 263.
    Subramanian KS, Meranger JE: Diurnal variations in the concentration of cadmium in urine. Clin Chem 30:1110, 1984.PubMedGoogle Scholar
  264. 264.
    Suskind RR, Hertzberg VS: Human health effects of 2,4,5-T and its toxic contaminants. JAMA 251:2372, 1984.PubMedCrossRefGoogle Scholar
  265. 265.
    Symposium on lead-blood pressure relationship. Environ Health Perspect 78:3–139, 1988.CrossRefGoogle Scholar
  266. 266.
    Tabershaw IR, Cooper WC: Sequela of acute organic phosphate poisoning. J Occup Med 8:5, 1966.PubMedGoogle Scholar
  267. 267.
    Tornqvist M, Mowrer J, Jensen S, et al: Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 154:255, 1986.PubMedCrossRefGoogle Scholar
  268. 268.
    Tornqvist M, Osterman-Golkar A, Kautiainen S, et al: Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7:1519, 1986.PubMedCrossRefGoogle Scholar
  269. 269.
    US EPA: Levels of Chemical Contaminants in Nonoccupational Exposed US Residents, EPA 000/1–80-002, EPA, Washington, 1980. Available from the National Technical Information Service, Springfield, VA 22161.Google Scholar
  270. 270.
    US EPA: Manual of Analytical Methods for the Analysis of Pesticides in Humans and Environmental Samples, Health Effects Research Laboratory, EPA-600/8–80-038, US EPA, Washington, 1980.Google Scholar
  271. 271.
    US EPA: Review of the NAAQS for Carbon Monoxide: Reassessment of Scientific and Technical Information. EPA-450/5–84-004, Office of Air Quality Planning Standards, US EPA, Washington, 1984.Google Scholar
  272. 272.
    US EPA: Suspended, Cancelled and Restricted Pesticides, 3rd rev, US EPA, Washington, 1985.Google Scholar
  273. 273.
    US EPA: Air Quality Criteria for Lead 6/86 and Addendum 9/86, EPA-600/8–83–018F, Office of Health and Environmental Assessment, US EPA, Washington, 1986.Google Scholar
  274. 274.
    Vainio H: Current trends in the biological monitoring of exposure to carcinogens. Scand J Work Environ Health 11:1, 1985.PubMedCrossRefGoogle Scholar
  275. 275.
    Vainio H, Sorsa M: Application of cytogenetic methods for biological monitoring. Annu Rev Public Health 4: 403, 1983.PubMedCrossRefGoogle Scholar
  276. 276.
    Vainio H, Sorsa M, Rantanen J, et al: Biological monitoring in the identification of the cancer risk of individuals exposed to chemical carcinogens. Scand J Work Environ Health 7:241, 1981.PubMedCrossRefGoogle Scholar
  277. 277.
    Vainio H, Sorsa M, Keirtminki K: Biological monitoring in surveillance of exposure to genotoxicants. Am J Ind Med 4:87, 1983.PubMedCrossRefGoogle Scholar
  278. 278.
    Vainio H, Sorsa M, Falck K: Bacterial urinary assay in monitoring exposure to mutagens and carcinogens. In: Monitoring of Human Exposure to Carcinogenic and Mutagenic Agents, p 247, Berlin A, Draper M, Hemminki K, et al. (eds.). International Agency for Research on Cancer, Lyon, 1984.Google Scholar
  279. 279.
    Valentine JL, Kang HK, Spivey G: Arsenic levels in human blood, urine and hair in response to exposure via drinking water. Environ Res 20:24, 1979.PubMedCrossRefGoogle Scholar
  280. 280.
    Van Sittert NJ, de Jong G, Clare MG, et al: Cytogenetic, immunological and hematological effects in workers in an ethylene oxide manufacturing plant. Br J Ind Med 42:19, 1985.PubMedGoogle Scholar
  281. 281.
    Wallis G, Barber T: Variability in urinary mercury excretion. J Occup Med 24:590, 1982.PubMedCrossRefGoogle Scholar
  282. 282.
    Warren AJ, Beck BD: Screening and monitoring for exposure and susceptibility to carcinogen. In: Variations in Susceptibility to Inhaled Pollutants, p 376, Brain JD, Beck BD, Warren AJ, et al. (eds.), The Johns Hopkins University Press, Baltimore, 1988.Google Scholar
  283. 283.
    Wedeen RP, Maesaka JK, Weiner B, et al: Occupational lead nephropathy. Am J Med 59:630, 1975.PubMedCrossRefGoogle Scholar
  284. 284.
    Wedeen RP, Malik DK, Batuman V: Detection and treatment of occupational lead nephropathy. Arch Intern Med 139:53, 1979.PubMedCrossRefGoogle Scholar
  285. 285.
    Weinstein IB: The monitoring of DNA adducts as an approach to carcinogen detection. Annu Rev Public Health 4:409, 1983.PubMedCrossRefGoogle Scholar
  286. 286.
    Weinstein IB: Molecular cancer epidemiology: The use of new laboratory methods in studies on human cancer causation. In: Epidemiology and Health Risk Assessment, p 159, Gordis L (ed.), Oxford University Press, Oxford, 1988.Google Scholar
  287. 287.
    Wetstone HJ, LaMotta RV: The clinical stability of serum Cholinesterase activity. Clin Chem 11:653, 1965.PubMedGoogle Scholar
  288. 288.
    Wogan GN, Gorelick NJ: Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect 62:5, 1985.PubMedCrossRefGoogle Scholar
  289. 289.
    Wolfe HR, Durham WF, Armstrong JF: Urinary excretion of insecticide metabolites—excretion of para-nitrophenol and DDA as indicators of exposure to parathion. Arch Environ Health 21:711, 1970.PubMedCrossRefGoogle Scholar
  290. 290.
    World Health Organization: Environmental Health Criteria 1, Mercury, World Health Organization, Geneva, 1976.Google Scholar
  291. 291.
    World Health Organization: Environmental Health Criteria 3, Lead, WHO, Geneva, 1977.Google Scholar
  292. 292.
    World Health Organization: Environmental Health Criteria 13, Carbon Monoxide, World Health Organization, Geneva, 1979.Google Scholar
  293. 293.
    World Health Organization: Report of a Study Group: Recommended Health-Based Limits in Occupational Exposure to Heavy Metals. Technical Report Series 647, World Health Organization, Geneva, 1980.Google Scholar
  294. 294.
    World Health Organization: Environmental Health Criteria 29, 2,4-Dichlorophenoxyacetic Acid, World Health Organization, Geneva, 1981.Google Scholar
  295. 295.
    World Health Organization: Field Surveys of Exposure to Pesticides: Standard Protocol, Division of Vector Biology and Control, World Health Organization, Geneva, 1982.Google Scholar
  296. 296.
    Xintaras C, Johnson BL, deGroot I (eds.): Behavioral Toxicology: Early Detection of Occupational Hazards, NIOSH Publication 74–126, US DHEW, Washington, 1974.Google Scholar
  297. 297.
    Yager J, McLean H, Hudes M, et al: Components of variability in blood Cholinesterase assay results. J Occup Med 18:242, 1976.PubMedGoogle Scholar
  298. 298.
    Yamasaki E, Ames BN: Concentration of mutagens from urine by absorption with nonpolar resin XAD-2: Cigarette smokers have mutagenic urine. Proc Natl Acad Sci USA, 74:3555, 1977.PubMedCrossRefGoogle Scholar
  299. 299.
    Yamashita F, Hayaski M: Fetal PCB syndrome: Clinical features, intrauterine growth retardation and possible alteration in calcium metabolism. Environ Health Perspect 59:41, 1985.PubMedCrossRefGoogle Scholar
  300. 300.
    Yule W, Rutter MI: Effect of lead on children’s behavior and cognitive performance: A critical review. In: Dietary and Environmental Lead: Human Health Effects, p 2, Mahaffey KR (ed.), Elsevier Press, Amsterdam, 1985.Google Scholar
  301. 301.
    Yule W, Lansdown R, Millar IB, et al: The relationship between blood lead concentrations, intelligence and attainment in a school population: A pilot study. Dev Med Child Neurol 23:567, 1981.PubMedCrossRefGoogle Scholar
  302. 302.
    Zielhuis RL: Biological monitoring. Scand J Work Environ Health 4:1, 1978.PubMedCrossRefGoogle Scholar

Recommended Readings

  1. Aitio A, Järvisalo J, Riihlmäki V, et al: Biological monitoring. In: Occupational Medicine Principles and Practical Applications, 2nd ed., p 178, Zenz C (ed.), Year Bood Medical Publishers, Chicago, 1988.Google Scholar
  2. Bartsch H, Hemminki K, O’Neill IK (eds.): Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, IARC Scientific Publication 89, International Agency For Research on Cancer, Lyon, 1988.Google Scholar
  3. Berlin A, Wolff AH, Hasegawa Y (eds.): The Use of Biological Specimens for the Assessment of Human Exposure to Environmental Pollutants, Martinus Nijhoff, The Hague, 1979.Google Scholar
  4. Committee on National Monitoring of Human Tissues, National Research Council: Monitoring Human Tissues for Toxic Substances, National Academy Press, 1991.Google Scholar
  5. Garner RC, Farmer PB, Steel GT, et al. (eds.): Human Carcinogen Exposure. Biomonitoring and Risk Asess-ment. Oxford University Press, Oxford, 1991.Google Scholar
  6. Hulka BS, Wilcosky TC, Griffith JD: Biological Markers in Epidemiology, Oxford University Press, Oxford, 1990.Google Scholar
  7. Lauwerys RR: Industrial Chemical Exposure—Guidelines for Biological Monitoring, Biomedical Publications, Davis, California, 1983.Google Scholar
  8. Sorsa M, Norppa H (eds.): Monitoring of Occupational Genotoxicants, Alan R Liss, New York, 1986.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • John D. Osterloh
  • Alyce Bezman Tarcher

There are no affiliations available

Personalised recommendations